Geographic and Segment Information

6 Months Ended

Jun. 30, 2022

Segment Reporting [Abstract]

Geographic and Segment Information

Note 18. Geographic and Segment Information

Geographic Information

Long-lived assets, which were composed of property and equipment, net by location, as of June 30, 2022 and December 31, 2021, were as follows:

	June 30,		December 31,
(in thousands)	2022		2021
United States	$	8,089	$	5,142
Australia		—		30
Total property and equipment, net	$	8,089	$	5,172

Segment Information

Our operating segment profit measure is segment loss from operations, which is calculated as revenue less cost of revenue, research and development, and general and administrative expenses. Profit and loss information by reportable segment for the three and six months ended June 30, 2022 and 2021 was as follows:

	Three Months Ended June 30,						Six Months Ended June 30,
(in thousands)	2022			2021			2022			2021
Drugs:
Revenue from external customers	$	—		$	—		$	—		$	—
Depreciation expense		(275	)		(244	)		(459	)		(477	)
Stock compensation expense		2,184			4,255			4,386			7,520
Loss from operations		(13,596	)		(13,421	)		(26,939	)		(25,086	)
Supplements:
Revenue from external customers	$	35		$	201		$	65		$	414
Depreciation expense		(12	)		(11	)		(23	)		(22	)
Stock compensation expense		—			—			—			—
Income (loss) from operations		1			(354	)		8			(384	)
Consolidated:
Revenue from external customers	$	35		$	201		$	65		$	414
Depreciation expense		(287	)		(255	)		(482	)		(499	)
Stock compensation expense		2,184			4,255			4,386			7,520
Loss from operations		(13,595	)		(13,775	)		(26,931	)		(25,470	)

A reconciliation of the total of the reportable segments’ loss from operations to consolidated net loss before income taxes for the three and six months ended June 30, 2022 and 2021 was as follows:

	Three Months Ended June 30,						Six Months Ended June 30,
(in thousands)	2022			2021			2022			2021
Segment loss from operations	$	(13,595	)	$	(13,775	)	$	(26,931	)	$	(25,470	)
Total other income (expense), net		9,061			10,352			9,043			(17,781	)
Net loss before income taxes	$	(4,534	)	$	(3,423	)	$	(17,888	)	$	(43,251	)

Segment assets exclude corporate assets, such as cash, restricted cash, and corporate facilities. Total assets by reportable segment as of June 30, 2022 and December 31, 2021, were as follows:

	June 30,		December 31,
(in thousands)	2022		2021
Total assets:
Drugs	$	17,617	$	12,052
Supplements		288		337
Corporate		26,637		50,674
Consolidated	$	44,542	$	63,063

Additions to long-lived assets were through cash expenditure, accounts payable, and a lease incentive representing an allowance for facility alterations. For the six months ended June 30, 2022 and 2021, total additions were as follows:

	Six Months Ended June 30,
(in thousands)	2022		2021
Drugs	$	3,399	$	420
Supplements		—		—
Corporate		—		—
Consolidated	$	3,399	$	420